Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schmoeckel

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
Biomedicines|August 29, 2024
Combination of Anti-CD40 and Anti-CD40L Antibodies as Co-Stimulation Blockade in Preclinical Cardiac XenotransplantationMartin Bender, Jan-Michael Abicht, Bruno Reichart, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
Biomedicines|August 29, 2024
Combination of Anti-CD40 and Anti-CD40L Antibodies as Co-Stimulation Blockade in Preclinical Cardiac XenotransplantationMartin Bender, Jan-Michael Abicht, Bruno Reichart, et al.
Pageof 9